Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Deininger

Showing results (51-60 of 160) with videos related to

Pageof 16
Sort By:
Blood Reviews|May 15, 2022
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an optionJeffrey H Lipton, Tim H Brümmendorf, Carlo Gambacorti-Passerini, et al.
Plos One|October 14, 2009
A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in miceKara J Johnson, Ian J Griswold, Thomas O'Hare, et al.
Blood|August 27, 2009
Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosisJennifer L Snead, Thomas O'Hare, Lauren T Adrian, et al.
Leukemia & Lymphoma|January 12, 2016
A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemiaSrinivas K Tantravahi, Philippe Szankasi, Jamshid S Khorashad, et al.
Journal of Hematology & Oncology|December 28, 2018
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel reviewJorge E Cortes, Jane F Apperley, Daniel J DeAngelo, et al.
Experimental Hematology|January 17, 2004
Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-AblIsabelle Gaston, Kara J Johnson, Tsukasa Oda, et al.
Cell Chemical Biology|November 8, 2024
Bioluminescence assay of lysine deacylase sirtuin activityAlexandria N Van Scoyk, Orlando Antelope, Donald E Ayer, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Comparison of colorimetric, fluorometric, and liquid chromatography-mass spectrometry assays for acetyl-coenzyme ADaniel S Kantner, Emily Megill, Anna Bostwick, et al.
Experimental Hematology|September 8, 2019
BCR-ABL1 tyrosine kinase inhibitor K0706 exhibits preclinical activity in Philadelphia chromosome-positive leukemiaOrlando Antelope, Nadeem A Vellore, Anthony D Pomicter, et al.
Experimental Hematology|April 28, 2015
Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasmAnthony D Pomicter, Anna M Eiring, Anna V Senina, et al.
Pageof 16

Showing results (51-60 of 160) with videos related to

Sort By:
Pageof 16
Blood Reviews|May 15, 2022
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an optionJeffrey H Lipton, Tim H Brümmendorf, Carlo Gambacorti-Passerini, et al.
Plos One|October 14, 2009
A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in miceKara J Johnson, Ian J Griswold, Thomas O'Hare, et al.
Blood|August 27, 2009
Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosisJennifer L Snead, Thomas O'Hare, Lauren T Adrian, et al.
Leukemia & Lymphoma|January 12, 2016
A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemiaSrinivas K Tantravahi, Philippe Szankasi, Jamshid S Khorashad, et al.
Journal of Hematology & Oncology|December 28, 2018
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel reviewJorge E Cortes, Jane F Apperley, Daniel J DeAngelo, et al.
Experimental Hematology|January 17, 2004
Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-AblIsabelle Gaston, Kara J Johnson, Tsukasa Oda, et al.
Cell Chemical Biology|November 8, 2024
Bioluminescence assay of lysine deacylase sirtuin activityAlexandria N Van Scoyk, Orlando Antelope, Donald E Ayer, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Comparison of colorimetric, fluorometric, and liquid chromatography-mass spectrometry assays for acetyl-coenzyme ADaniel S Kantner, Emily Megill, Anna Bostwick, et al.
Experimental Hematology|September 8, 2019
BCR-ABL1 tyrosine kinase inhibitor K0706 exhibits preclinical activity in Philadelphia chromosome-positive leukemiaOrlando Antelope, Nadeem A Vellore, Anthony D Pomicter, et al.
Experimental Hematology|April 28, 2015
Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasmAnthony D Pomicter, Anna M Eiring, Anna V Senina, et al.
Pageof 16